NEW YORK (GenomeWeb) – San Francisco-based uBiome today announced the launch of its CLIA laboratory to provide clinical testing based on its microbial assays.

The tests, which evaluate the patient's microbiome for "clinically relevant results," were developed in part with data gathered in a citizen science project, the firm said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.